I don't like boasting ... But I told you !!! News
Post# of 148163
These are VERY good numbers. Haven't studied the document carefully but ANY drug that can reduce CAMS and CTC and has shown a correlation to increased (300%) mOFS and (450%) 12 month OS is bound to be a solid candidate to a good chunk of the more than 100 Billion (only USA, 2019) oncology market.
I don't care about the SP today (which under a rational environment should skyrocket and probably won't), but, simply put: if this repeats in a larger sample we are GOLDEN
Very good news fellow longs !!!!